FDA product code PMI: Fluorescence In Situ Hybridization, Platelet-Derived Growth Factor Receptor, Beta Polypeptide (Pdgfrb), Rearrangement

PMI is the FDA product code for fluorescence in situ hybridization, platelet-derived growth factor receptor, beta polypeptide (pdgfrb), rearrangement. It is a Class III device, reviewed by the Medical Genetics panel. Devices under PMI reach the market by Unclassified; FDA lists no cleared 510(k)s for it.

Definition

A fluorescence in situ hybridization (FISH) assay for PDGFRB rearrangement is a qualitative in vitro diagnostic assay to detect large rearrangements or translocations within the PDGFRB gene locus. It is indicated as an aid in the assessment of patients for whom treatment with tyrosine kinase inhibitors might be appropriate.

Classification

FieldValue
Device nameFluorescence In Situ Hybridization, Platelet-Derived Growth Factor Receptor, Beta Polypeptide (Pdgfrb), Rearrangement
Device classClass III
Review panelMG — Medical Genetics
Medical specialtyUnknown
Premarket routeUnclassified

Recalls for PMI devices

FDA recall records list no recalls for product code PMI.

Frequently asked questions

What is FDA product code PMI?

PMI is the FDA product code for fluorescence in situ hybridization, platelet-derived growth factor receptor, beta polypeptide (pdgfrb), rearrangement. It is a Class III device, reviewed by the Medical Genetics panel.

What device class is PMI?

Class III. Typical premarket route: Unclassified.

Next steps

Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.

All Medical Genetics product codes · FDA product code lookup · 510(k) database search · 510(k) review times